233 related articles for article (PubMed ID: 36282488)
1. Ganglioside-Functionalized Nanoparticles for Chimeric Antigen Receptor T-Cell Activation at the Immunological Synapse.
Zang H; Siddiqui M; Gummuluru S; Wong WW; Reinhard BM
ACS Nano; 2022 Nov; 16(11):18408-18420. PubMed ID: 36282488
[TBL] [Abstract][Full Text] [Related]
2. Dressing up Nanoparticles: A Membrane Wrap to Induce Formation of the Virological Synapse.
Yu X; Xu F; Ramirez NG; Kijewski SD; Akiyama H; Gummuluru S; Reinhard BM
ACS Nano; 2015; 9(4):4182-92. PubMed ID: 25853367
[TBL] [Abstract][Full Text] [Related]
3. Chimeric antigen receptor T cells targeting the GM3(Neu5Gc) ganglioside.
Heinzelbecker J; Fauskanger M; Jonson I; Krengel U; Løset GÅ; Munthe L; Tveita A
Front Immunol; 2024; 15():1331345. PubMed ID: 38370401
[TBL] [Abstract][Full Text] [Related]
4. Immunological Synapse Predicts Effectiveness of Chimeric Antigen Receptor Cells.
Xiong W; Chen Y; Kang X; Chen Z; Zheng P; Hsu YH; Jang JH; Qin L; Liu H; Dotti G; Liu D
Mol Ther; 2018 Apr; 26(4):963-975. PubMed ID: 29503199
[TBL] [Abstract][Full Text] [Related]
5. Membrane-wrapped nanoparticles probe divergent roles of GM3 and phosphatidylserine in lipid-mediated viral entry pathways.
Xu F; Bandara A; Akiyama H; Eshaghi B; Stelter D; Keyes T; Straub JE; Gummuluru S; Reinhard BM
Proc Natl Acad Sci U S A; 2018 Sep; 115(39):E9041-E9050. PubMed ID: 30190430
[TBL] [Abstract][Full Text] [Related]
6. The Role of Immunological Synapse in Predicting the Efficacy of Chimeric Antigen Receptor (CAR) Immunotherapy.
Liu D; Badeti S; Dotti G; Jiang JG; Wang H; Dermody J; Soteropoulos P; Streck D; Birge RB; Liu C
Cell Commun Signal; 2020 Aug; 18(1):134. PubMed ID: 32843053
[TBL] [Abstract][Full Text] [Related]
7. CAR T cells targeting the ganglioside NGcGM3 control ovarian tumors in the absence of toxicity against healthy tissues.
Cribioli E; Giordano Attianese GMP; Coukos G; Irving M
Front Immunol; 2022; 13():951143. PubMed ID: 35990626
[TBL] [Abstract][Full Text] [Related]
8. Learning from TCR Signaling and Immunological Synapse Assembly to Build New Chimeric Antigen Receptors (CARs).
Cassioli C; Patrussi L; Valitutti S; Baldari CT
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430728
[TBL] [Abstract][Full Text] [Related]
9. Imaging CAR-T Synapse as a Quality Control for CAR Engineering.
Xiao Q; Su X
Methods Mol Biol; 2023; 2654():503-512. PubMed ID: 37106204
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of Toll-Like Receptor Ligands and Inflammasome Stimuli in GM3 Liposomes to Induce Dendritic Cell Maturation and T Cell Responses.
Nijen Twilhaar MK; Czentner L; Bouma RG; Olesek K; Grabowska J; Wang AZ; Affandi AJ; Belt SC; Kalay H; van Nostrum CF; van Kooyk Y; Storm G; den Haan JMM
Front Immunol; 2022; 13():842241. PubMed ID: 35251040
[TBL] [Abstract][Full Text] [Related]
11. Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells.
Wu L; Wei Q; Brzostek J; Gascoigne NRJ
Cell Mol Immunol; 2020 Jun; 17(6):600-612. PubMed ID: 32451454
[TBL] [Abstract][Full Text] [Related]
12. Combining the best of two worlds: highly flexible chimeric antigen receptor adaptor molecules (CAR-adaptors) for the recruitment of chimeric antigen receptor T cells.
Darowski D; Kobold S; Jost C; Klein C
MAbs; 2019; 11(4):621-631. PubMed ID: 30892136
[TBL] [Abstract][Full Text] [Related]
13. Expanding the Therapeutic Window for CAR T Cell Therapy in Solid Tumors: The Knowns and Unknowns of CAR T Cell Biology.
Watanabe K; Kuramitsu S; Posey AD; June CH
Front Immunol; 2018; 9():2486. PubMed ID: 30416506
[TBL] [Abstract][Full Text] [Related]
14. Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies.
Mamonkin M; Mukherjee M; Srinivasan M; Sharma S; Gomes-Silva D; Mo F; Krenciute G; Orange JS; Brenner MK
Cancer Immunol Res; 2018 Jan; 6(1):47-58. PubMed ID: 29079655
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy.
Nawaz W; Xu S; Li Y; Huang B; Wu X; Wu Z
Acta Biomater; 2020 Jun; 109():21-36. PubMed ID: 32294554
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle-Based Chimeric Antigen Receptor Therapy for Cancer Immunotherapy.
Shin S; Lee P; Han J; Kim SN; Lim J; Park DH; Paik T; Min J; Park CG; Park W
Tissue Eng Regen Med; 2023 Jun; 20(3):371-387. PubMed ID: 36867402
[TBL] [Abstract][Full Text] [Related]
17. Liposome induction of CD8
Grabowska J; Affandi AJ; van Dinther D; Nijen Twilhaar MK; Olesek K; Hoogterp L; Ambrosini M; Heijnen DAM; Klaase L; Hidalgo A; Asano K; Crocker PR; Storm G; van Kooyk Y; den Haan JMM
J Control Release; 2021 Mar; 331():309-320. PubMed ID: 33493613
[TBL] [Abstract][Full Text] [Related]
18. In vitro machine learning-based CAR T immunological synapse quality measurements correlate with patient clinical outcomes.
Naghizadeh A; Tsao WC; Hyun Cho J; Xu H; Mohamed M; Li D; Xiong W; Metaxas D; Ramos CA; Liu D
PLoS Comput Biol; 2022 Mar; 18(3):e1009883. PubMed ID: 35303007
[TBL] [Abstract][Full Text] [Related]
19. Methods of Machine Learning-Based Chimeric Antigen Receptor Immunological Synapse Quality Quantification.
Gan J; Cho JH; Lee R; Naghizadeh A; Poon LY; Wang E; Hui Z; Liu D
Methods Mol Biol; 2023; 2654():493-502. PubMed ID: 37106203
[TBL] [Abstract][Full Text] [Related]
20. Liposomal Nanovaccine Containing α-Galactosylceramide and Ganglioside GM3 Stimulates Robust CD8
Grabowska J; Stolk DA; Nijen Twilhaar MK; Ambrosini M; Storm G; van der Vliet HJ; de Gruijl TD; van Kooyk Y; den Haan JMM
Vaccines (Basel); 2021 Jan; 9(1):. PubMed ID: 33467048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]